Randomized controlled trials of psychological and pharmacological treatments for nightmares: a meta-analysis

Sleep Med Rev. 2013 Apr;17(2):143-52. doi: 10.1016/j.smrv.2012.06.001. Epub 2012 Oct 6.

Abstract

A meta-analysis of treatments for nightmares is reported. The studies were identified by database searches and by an inspection of relevant reference lists. The inclusion criteria were: nightmares as a target problem, studies published in English, use of a randomized controlled trials and reporting of nightmare-relevant outcomes. A total of 19 studies, published between 1978 and 2012 were identified, which included 1285 participants. Effect sizes were calculated as Cohen's d. A statistically significant improvement for all studies combined (d = 0.47, 95% CI = 0.33-0.60, fixed effects model; d = 0.49, 95% CI = 0.32-0.66, random effects model) and for psychological treatments alone (d = 0.48, 95% CI = 0.36-0.60, random) and for prazosin alone (d = 0.50, 95% CI = 0.03-0.96, random) was found. Individual therapy format yielded a higher effect size than a self-help format (p = 0.03). Minimal interventions (relaxation, recording) yielded lower overall effect size than studies offering more extensive interventions (p = 0.02). It is concluded that there are both psychological and pharmacological interventions which have documented effects for the treatment of nightmares.

Publication types

  • Meta-Analysis

MeSH terms

  • Combined Modality Therapy
  • Dreams / drug effects*
  • Dreams / psychology
  • Humans
  • Night Terrors / drug therapy
  • Night Terrors / therapy*
  • Prazosin / therapeutic use
  • Psychotherapy
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Substances

  • Prazosin